Key facts
as of Sep 2026- TowardPi’s last known valuation is $22.8M (Oct 2019).
- It has raised $253.4M; the latest was Later Stage VC ($58.1M) in Mar 2026.
- Notable investors include Qiming Venture Partners, Legend Capital, Beijing State-owned Capital Operation and Management, TusStar Incubator, Tsing Stone Asset Management — 27 tracked in total.
- 1 institutional filer reports fund marks on TowardPi across 1 filings.
- Status: Privately Held (backing).
- ·The complete investor list — 27 names
- ·Watchlist + deal alerts for TowardPi
- ·The full record, as it builds
Recorded secondary trades
No secondary trades in TowardPi shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
1 filers · latest Apr 20261 SEC-registered fund reported 1 fair-value mark on TowardPi between Apr 2026 and Apr 2026. Filer-level marks and implied $/share are available to Pro members.
Funding rounds
No funding rounds for TowardPi are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About TowardPi
Developer of ophthalmic medical equipment designed to detect and diagnose eye diseases. The company's equipment includes an optical coherence tomography (OCT) retinal diagnostic system, which can be used in non-invasive imaging tests and takes cross-sectional pictures of the patient's retina, enabling ophthalmologists to diagnose deformities or illnesses in the eye.
- Sector
- Healthcare
- HQ
- Beijing, China
- Founded
- 2017
- Employees
- 300
- Website
- towardpi.com/
- Ownership
- Privately Held (backing)